CANT1 and hepatocellular carcinoma: Many studies have demonstrated that HCC patients with mutated TP53 have adverse prognosis, which provided new insights into personalized prognostication approaches [25].The present study analyzed CANT1 expression in 33 tumors by downloading RNAseq from TCGA and GTEx databases, and revealed high expression of CANT1 in some tumors, including HCC.